Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003468047 | SCV004193537 | likely pathogenic | Retinitis pigmentosa 25 | 2023-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003939055 | SCV004755493 | pathogenic | EYS-related disorder | 2023-11-22 | no assertion criteria provided | clinical testing | The EYS c.1505_1506insGA variant is predicted to result in a frameshift and premature protein termination (p.Phe502Leufs*14). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in EYS are expected to be pathogenic. Therefore, we interpret this variant as pathogenic. |